{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-077725","form_type":"8-K","ticker":"CC","cik":"0001627223","company_name":"Chemours Co","filed_at":"2024-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.858069+00:00","generated_at":"2026-06-04T07:53:46.672363+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Chemours schedules Q4/FY23 earnings release for March 27, conference call March 28","bullets":["Expects to issue Q4 and full-year 2023 financial results after market close on March 27, 2024.","Annual Report on Form 10-K for year ended December 31, 2023 also to be filed March 27.","Conference call to discuss results at 8:00 a.m. EDT on March 28, 2024; webcast on investors.chemours.com.","Interim CFO Matthew Abbott signed the filing; no financial results disclosed in this 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-077725","json":"https://secwatch.observer/filing/0001193125-24-077725.json","markdown":"https://secwatch.observer/filing/0001193125-24-077725.md","text":"https://secwatch.observer/filing/0001193125-24-077725.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524077725/0001193125-24-077725-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524077725/d782971d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T07:53:46.672363+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}